Alamar Biosciences, Inc. (ALMR) News
Track canonical SquawkNews coverage tagged to ALMR, Alamar Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32
Stifel analyst Daniel Arias maintains Alamar Biosciences (NASDAQ: ALMR ) with a Buy and raises the price target from $28 to $32.
EQUITY | Aug 11, 2026, 05:41 PM UTC
L
Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum
Alamar Biosciences Inc. (NASDAQ: ALMR ) shares are trading higher on Tuesday as the company is expanding its global partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures. The proteomics company is e
EARNINGS | Aug 11, 2026, 05:25 PM UTC